ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 30820185

Importance of Copy Number Alterations of FGFR1 and C-MYC Genes in Triple Negative Breast Cancer.

Nedeljković M and 8 others. J Med Biochem, 2019. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Importance of Copy Number Alterations of FGFR1 and C-MYC Genes in Triple Negative Breast Cancer. Papers, record 30820185. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30820185

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Importance of Copy Number Alterations of FGFR1 and C-MYC Genes in Triple Negative Breast Cancer.
PubMed
Journal
J Med Biochem
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.31
iCite
Revised in PubMed
2022-04-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nedeljković MMilica
2Tanić NNikola
3Dramićanin TTatjana
4Milovanović ZZorka
5Šušnjar SSnežana
6Milinković VVedrana
7Vujović IIvana
8Prvanović MMirjana
9Tanić NNasta

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111,002,770
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC.
J Clin Pathol2000https://conductscience.org/library/papers/11002770PubMed
211,021,963c-Myc in breast cancer.Endocr Relat Cancer2000https://conductscience.org/library/papers/11021963PubMed
311,104,567C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance.Br J Cancer2000https://conductscience.org/library/papers/11104567PubMed
415,083,194Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.Br J Cancer2004https://conductscience.org/library/papers/15083194PubMed
515,574,759Prognostic relevance of gene amplifications and coamplifications in breast cancer.Cancer Res2004https://conductscience.org/library/papers/15574759PubMed
616,497,871c-myc amplifications in primary breast carcinomas and their local recurrences.J Clin Pathol2006https://conductscience.org/library/papers/16497871PubMed
716,527,609The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma.Cancer Genet Cytogenet2006https://conductscience.org/library/papers/16527609PubMed
817,159,189American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.J Clin Oncol2007https://conductscience.org/library/papers/17159189PubMed
917,397,528FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.Breast Cancer Res2007https://conductscience.org/library/papers/17397528PubMed
1017,671,126Triple-negative breast cancer: clinical features and patterns of recurrence.Clin Cancer Res2007https://conductscience.org/library/papers/17671126PubMed

1 to 10 of 31

See all 31 references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42,591,661FGFR1 copy number gain is independently associated with shorter progression-free survival in advanced lung squamous cell carcinoma treated with first-line immune checkpoint inhibitor-based therapy.Front Immunol2026https://conductscience.org/library/papers/42591661PubMed
36,930,419Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.Breast Cancer2023https://conductscience.org/library/papers/36930419PubMed
34,249,978Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient.Front Med (Lausanne)2021https://conductscience.org/library/papers/34249978PubMed
33,223,752Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells.Chin J Cancer Res2020https://conductscience.org/library/papers/33223752PubMed
31,754,359The Relationship Between Fibroblastic Growth Factor Receptor-1 (FGFR1) Gene Amplification in Triple Negative Breast Carcinomas and Clinicopathological Prognostic Factors.Iran J Pathol2019https://conductscience.org/library/papers/31754359PubMed

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22,064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2,069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
FGFR12,260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
MYC4,609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
PGR5,241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30820185

GET https://conductscience.org/api/papers/v1/30820185/references?page=2

API referenceFor AI assistants